The utility of 6-month protocol renal biopsy under modern immunosuppression.
Clin Nephrol 70(6):490-5 (2008) PMID 19049705
Protocol biopsies after renal transplantation are useful in detecting subclinical rejection. In earlier studies, the incidence of subclinical rejection was high among renal transplant recipients on a cyclosporine-based immunosuppression. However, recent data show that subclinical rejection is low under tacrolimus-based immunosuppression. This study evaluates the utility of 6-month protocol biopsy in renal transplant recipients under induction with rabbit antithymocyte globulin and maintenance immunosuppression with tacrolimus, mycophenolate mofetil (MMF) and corticosteroids.
Version: za2963e q8za2 q8zba q8zcb q8zd8 q8ze6 q8zf0 q8zg8